AIM ImmunoTech Inc. (AIM)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, AIM ImmunoTech Inc. reported revenue of $88.0K, down 48.2% from the prior year. The company ran a net loss, with a net margin of -15861.4%. It held $5.78M in total assets against $15.56M in total liabilities.
Key ratios (FY2025)
-13254.5%
Operating margin
-15861.4%
Net margin
-48.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $170.0K | $202.0K | $141.0K | — | — | — | $367.0K | $437.0K | — |
| Operating Income | -$11.66M | -$19.77M | -$31.92M | -$19.92M | -$18.84M | -$15.15M | -$12.44M | -$11.50M | -$11.42M | -$13.80M |
| Net Income | -$13.96M | -$17.32M | -$28.96M | -$19.45M | -$19.13M | -$14.40M | -$9.40M | -$9.83M | -$8.26M | -$7.50M |
| EPS (Diluted) | $-8.62 | $-30.92 | $-0.60 | $-0.40 | $-0.40 | — | — | — | — | — |
| Total Assets | $5.78M | $8.61M | $19.38M | $40.49M | $57.70M | $64.58M | $20.75M | $13.85M | $14.21M | $18.87M |
| Total Liabilities | $15.56M | $9.93M | $9.15M | $2.02M | — | — | — | — | — | — |
| Shareholders' Equity | -$9.78M | -$1.32M | $10.23M | $38.47M | $56.88M | $61.29M | $13.44M | $5.58M | $8.70M | $15.50M |
| Cash & Equivalents | $2.98M | $1.70M | $5.44M | $27.05M | $32.09M | $38.50M | $1.47M | $299.0K | $1.41M | $2.41M |
| Operating Cash Flow | -$10.96M | -$14.89M | -$21.27M | -$16.11M | -$13.96M | -$10.37M | -$9.07M | -$10.64M | -$7.94M | -$7.38M |
| Capital Expenditures | — | $18.0K | — | $86.0K | $41.0K | $22.0K | $68.0K | $51.0K | $20.0K | $160.0K |
| Shares Outstanding | 3.07M | 655.3K | 49.10M | 48.08M | 47.99M | 42.15M | 10.39M | 1.11M | 32.88M | 24.20M |